Evaluation of ovulation and safety outcomes in a multi-center randomized trial of three 84 day ulipristal acetate regimens-Reference-Cited by-同舟云学术

Evaluation of ovulation and safety outcomes in a multi-center randomized trial of three 84 day ulipristal acetate regimens

Published:2022-08 Issue: Volume:112 Page:54-60
ISSN:0010-7824
Container-title:Contraception
language:en
Short-container-title:Contraception

Author:

Westhoff Carolyn L,Archer David F.,Barnhart Kurt,Darney Philip,Gilliam Melissa,Jensen Jeffrey,Nelson Anita,Teal Stephanie,Thomas Michael,Hu Jack,Brown Jill,Blithe Diana L

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference18 articles.

1. Development of the selective progesterone receptor modulator CDB-2914 for clinical indications;Blithe;Steroids,2003

2. Daily low-dose mifepristone has contraceptive potential by suppressing ovulation and menstruation: A double-blind randomized control trial of 2 and 5 mg per day for 120 days;Brown;J Clin Endocrinol Metab,2002

3. A novel estrogen-free oral contraceptive pill for women: multicenter double-blind, randomized controlled trial of mifepristone and progestogen-only pill (levonorgestrel);Lahka;Human Reproduction,2007

4. The selective progesterone receptor modulator ulipristal acetate inhibits the activity of the glucocorticoid receptor;Small;J Clin Endocrin Metab,2020

5. Progesterone receptor modulator for emergency contraception: A randomized controlled trial;Creinin;Obstet Gynecol,2006

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emergency contraception for individuals weighing 80 kg or greater: A randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrel;Contraception;2024-09

2. A randomized single-blind non-inferiority trial of delayed start with drospirenone-only and ethinyl estradiol-gestodene pills for ovulation inhibition;Scientific Reports;2024-06-19

3. Pharmacodynamic evaluation of the etonogestrel contraceptive implant initiated midcycle with and without ulipristal acetate: An exploratory study;Contraception;2024-04

4. Current and Emerging Treatment Options for Uterine Fibroids;Drugs;2023-11-03

5. Using transvaginal ultrasounds for the identification of follicle‐like structures ≥10 mm in a multi‐center randomized contraceptive clinical trial of three 84‐day oral ulipristal acetate regimens;Journal of Clinical Ultrasound;2022-12-10